Min W. Peng
2Department Of Oncology, No. 238 Jiefang Road
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Ligand-Receptor Interaction Combined with Histopathology Improves Glioma Prognostic Model.
Journal: Biomedicines
Published: March 21, 2026
Predicting postpartum hemorrhage in placenta accreta spectrum patients with prophylactic abdominal aorta balloon occlusion: a retrospective cohort study.
Journal: Archives of gynecology and obstetrics
Published: February 17, 2026
Integrated analysis identifies a palmitoylation-associated prognostic model (ACSM5/SKA3) for lung adenocarcinoma across multiple cohorts.
Journal: PeerJ
Published: September 24, 2025
DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 07, 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity.
Journal: Frontiers in immunology
Published: November 26, 2024
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study.
Journal: The Lancet. Oncology
Published: October 30, 2024
Epidemiological characteristics of human respiratory syncytial virus in Hubei Province from 2016 to 2023
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: August 14, 2024
Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage Ⅳ Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN Study.
Journal: Clinical lung cancer
Published: May 04, 2024
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study.
Journal: Signal transduction and targeted therapy
Published: February 07, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: November 27, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Journal: Thoracic cancer
Published: October 25, 2023
Last Updated: 09/26/2026